Skip to content

Clinical trials

Phase 2 Hypoparathyroidism trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypoparathyroidism Phase: Phase 2 Country / region: United States Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20081
20101
20141
20191
20231
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
MBX Biosciences2
Ascendis Pharma A/S1
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)1
Mayo Clinic1
National Institute of Dental and Craniofacial Research (NIDCR)1
National Institutes of Health Clinical Center (CC)1
Shire1
Sumitomo Pharma Switzerland GmbH1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypoparathyroidism9
Hypocalcemia4
Thyroid Diseases2
DiGeorge Syndrome1
Endocrine System Diseases1
Immunologic Deficiency Syndromes1
Parathyroid Diseases1
Polyendocrinopathies, Autoimmune1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.